Date: August 12, 2020 Source 1: Harvard Medical School Source 2: www.sciencedaily.com Summary: New drug regimen for multidrug-resistant tuberculosis shows early effectiveness in 85 percent of patients in a cohort including many with serious comorbidities. The results suggest a global Read More …